Estimaciones de analistas de Wall Street para IRIDEX Corporation (IRIX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 3 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 4 |
| Calificación media (1-5) | 0.75 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-17 | $-0.04 | ||
| 2026-08-18 | $-0.07 | $-0.01 | -600.0% |
| 2026-05-19 | $-0.03 | $-0.07 | +57.1% |
| 2026-03-26 | $-0.01 | $-0.02 | +50.0% |
| 2025-11-11 | $-0.09 | $-0.02 | -350.0% |
| 2025-08-12 | $-0.06 | $-0.09 | +33.3% |
| 2025-05-13 | $-0.10 | $-0.10 | +0.0% |
| 2025-03-27 | $-0.05 | $-0.05 | +0.0% |
Ratios de valoración
| Precio / Valor contable | 2.90 |
| EV / EBITDA | -6.71 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $46.2M | $41.6M | $42.6M | $43.4M | $36.3M | $53.9M | $57.0M | $51.9M | $48.7M | $52.7M |
| Coste de Ventas | $25.3M | $26.1M | $25.1M | $25.5M | $20.8M | $31.1M | $31.6M | $30.1M | $29.2M | $33.4M |
| Beneficio Bruto | $20.8M | $15.5M | $17.5M | $17.9M | $15.6M | $22.8M | $25.4M | $21.8M | $19.5M | $19.3M |
| I+D | $5.4M | $5.7M | $4.0M | $3.7M | $3.3M | $6.9M | $7.2M | $6.8M | $5.4M | $3.7M |
| Generales y Administrativos | $17.9M | $22.8M | $26.3M | $23.2M | $18.9M | $23.5M | $25.7M | $25.0M | $22.4M | $18.1M |
| Gastos Operativos | $23.3M | $28.5M | $30.3M | $26.9M | $22.1M | $30.4M | $32.9M | $31.8M | $27.8M | $21.9M |
| Beneficio Operativo | -$2.6M | -$12.9M | -$12.9M | -$9.0M | -$6.6M | -$7.5M | -$7.5M | -$10.0M | -$8.3M | -$2.6M |
| EBITDA | -$1.8M | -$12.2M | -$12.1M | -$8.3M | -$6.1M | -$4.4M | -$6.1M | -$7.4M | -$7.4M | -$2.8M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.7M | -$13.0M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.5M | -$8.8M | -$4.4M |
| Impuestos | $9.1M | -$128000 | $37000 | $48000 | $26000 | $40000 | $65000 | $90000 | $68000 | $57000 |
| Beneficio Neto | -$11.7M | -$12.9M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.6M | -$8.9M | -$4.4M |
| BPA | $-1.15 | $-1.11 | $-1.05 | $-0.64 | $-0.46 | $-0.34 | $-0.47 | $-0.59 | $-0.54 | $-0.26 |
| BPA Diluido | $-1.15 | $-1.11 | $-1.05 | $-0.64 | $-0.46 | $-0.34 | $-0.47 | $-0.59 | $-0.54 | $-0.26 |
| Acciones en Circulación (Diluidas) | $10.2M | $11.6M | $12.2M | $13.7M | $13.8M | $15.4M | $15.9M | $16.1M | $16.4M | $17.2M |
Precio
| Precio | $0.61 |
| Capitalización | $11M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADGM · ALUR · ASBP · COCH · HOTH · IINN · NVNO
Explorar sector: Healthcare · Medical - Devices
Más secciones de IRIX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones